Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Invested Capital (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Invested Capital data on record, last reported at $131.8 million in Q2 2025.

  • For Q2 2025, Invested Capital fell 3.1% year-over-year to $131.8 million; the TTM value through May 2025 reached $131.8 million, down 3.1%, while the annual FY2025 figure was $131.8 million, 3.1% down from the prior year.
  • Invested Capital reached $131.8 million in Q2 2025 per LFCR's latest filing, up from $127.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $366.8 million in Q2 2021 and bottomed at $75.3 million in Q3 2023.
  • Average Invested Capital over 5 years is $177.3 million, with a median of $135.0 million recorded in 2023.
  • Peak YoY movement for Invested Capital: crashed 57.34% in 2023, then surged 68.7% in 2024.
  • A 5-year view of Invested Capital shows it stood at $280.3 million in 2021, then crashed by 39.31% to $170.1 million in 2022, then plummeted by 44.57% to $94.3 million in 2023, then skyrocketed by 34.44% to $126.8 million in 2024, then rose by 3.96% to $131.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $131.8 million in Q2 2025, $127.2 million in Q1 2025, and $126.8 million in Q4 2024.